Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government

Office of Research & Development

print icon sign up for VA Research updates

ePROS Webinars

webinars banner

ePROS is pleased to announce a series of webinars focusing on topics on a variety of topics. Each session will allow time for questions.

Upcoming Webinars



Date Time Title Presenters
06/18/2024 2:30 PM EDT Implementation of VHA Directive 1200.13: Financial Conflicts of Interest and Interest and Outside Compensation for Performance in VA Research (May 2, 2024)

Target Audience: VA research leadership and administrators; R&D Committee Chairs and members; VA Investigators; interested members of the VA research community

Teams Link : Click here to join the meeting

Objectives: The presenters for this webinar will be Tony Laracuente, MBA; Director of Field Operations; ORD; Karen Jeans,PhD, CCRN, CIP; Director of Regulatory Affairs, EPROS; ORD; Angela ‘Angie’ Foster, MS, FAC-P/PM Senior Level; Program Manager, EPROS;ORD; and Christopher Britt, JD; VA Office of General Counsel Ethics Specialty Team.

The purpose of this webinar is to describe the implementation requirements for the new VHA Directive 1200.13: Financial Conflicts of Interest and Outside Compensation for Performance in VA research.

At the conclusion of the webinar, learners will:

  1. Describe the key responsibilities required by VHA Directive 1200.13 for VA Medical Center Director, ACOS/R, AO/R, R&D Committee, Financial Conflict of Interest (FCOI) Administrators, and VA Investigators;
  2. Identify key requirements for submission and review of the Research Financial Conflict of Interest (FCOI) Statement, OGE Form 450 Alternative-VA (“Alt-450”);
  3. Describe how training for Financial Conflict of Interest Administrators’ training for review of the OGE 450 Alt-450 VA will be conducted; and
  4. Identify training resources provided by ORD on the VAIRRS Research Conflict of Interest Module.

C. Karen Jeans, Director of Regulatory Affairs, EPROS; ORD
06/21/2024 12 PM EDT Serious Adverse Event (SAE) Reporting for National Cancer Institute's (NCI) National Clinical Trials Network (NCTN) Trials (ID:87)

Target Audience: Research teams that manage NCTN (e.g., SWOG, Alliance, ECOG-ACRIN, or NRG) trials

Teams Link: Click here to join the meeting

Objectives:

Please join Maggie Spillers (SWOG), Sara McCartney (NRG), Rombi Wake-Oliver (Alliance), and Josh Schoppe (ECOG-ACRIN) for a presentation on serious adverse event (SAE) reporting expectations, CTEP-AERS application, practice examples and available resources with an opportunity to ask questions following the presentation.

Stephanie Ferguson, NAVIGATE National Program Manager
06/25/2024 3:00 PM EDT Field Finance Training: RAFT and Balancing to the Status of Allowance

Target Audience: Field Administrative Officers, Budget Analysts

Teams Link: Click here to join the meeting

Objectives:

Learn tools and tips for accurate project-level financial tracking and balancing to the Status of Allowance (SOA).

Make time to attend this informative training to prepare for upcoming Q3 RAFT expenditure reporting.

Kari Points, Director, Research Operations Iowa City


FAQ

If I'm unable to attend this webinar session, will it be available again?

Webinar sessions are generally only presented live once, unless otherwise indicated. However, all efforts will be made to have webinar sessions recorded and made available in our archive. Please allow 3-5 working days for webinars to be posted.

How will I receive audio for the webinar session?

The audio will be streamed through your computer. Turn on your speakers or plug in your headphones; the audio is automatically streamed. If you do not have speakers or a sound card, audio will be available via telephone; the number to call will be on your confirmation e-mail.

Who do I email for help?

Please submit technical issues through yourIT Service Portal.



Questions about the R&D website? Email the Web Team

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.